SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs
Development · 15.07.2023 · 150 (14)
DOI: 10.1242/dev.201509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, online erschienen am 13.07.2023. Verfasst von Olga G Jaime und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Pluripotent Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The earliest skeletal muscle progenitor cells (SMPCs) derived from human pluripotent stem cells (hPSCs) are often identified by factors expressed by a diverse number of progenitors. An early transcriptional checkpoint that defines myogenic commitment could improve hPSC differentiation to skeletal muscle. Analysis of several myogenic factors in human embryos and early hPSC differentiations found SIX1+PAX3+ co-expression was most indictive of myogenesis. Using dCas9-KRAB hPSCs, we demonstrate that early inhibition of SIX1 alone significantly decreased PAX3 expression, reduced PAX7+ SMPCs, and myotubes later in differentiation. Emergence of SIX1+PAX3+ precursors can be improved by manipulating seeding density, monitoring metabolic secretion and altering the concentration of CHIR99021. These modifications resulted in the co-emergence of hPSC-derived sclerotome, cardiac and neural crest that we hypothesized enhanced hPSC myogenic differentiation. Inhibition of non-myogenic lineages modulated PAX3 independent of SIX1. To better understand SIX1 expression, we compared directed differentiations to fetal progenitors and adult satellite cells by RNA-seq. Although SIX1 continued to be expressed across human development, SIX1 co-factor expression was dependent on developmental timing. We provide a resource to enable efficient derivation of skeletal muscle from hPSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
- Sue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA 92697, USA.
- Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
ORCID-Profile: Michael R Hicks
Förderung
- NCATS NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NIAMS NIH HHS
- California Institute of Regenerative Medicine
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Muscular Dystrophy Association
Zitieren
APA
Jaime, O. G., Arias, J., Pavani, S., Pyle, A. D., & Hicks, M. R. (2023). SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs. Development, 150(14). https://doi.org/10.1242/dev.201509
Vancouver
Jaime OG, Arias J, Pavani S, Pyle AD, Hicks MR. SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs. Development. 2023;150(14). doi:10.1242/dev.201509
BibTeX
@article{Jaime2023,
author = {Jaime, Olga G and Arias, Jessica and Pavani, Shreya and Pyle, April D and Hicks, Michael R},
title = {SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs},
journal = {Development},
year = {2023},
volume = {150},
number = {14},
doi = {10.1242/dev.201509}
}
EUVIMED